Richards, Merrill & Peterson’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Richards, Merrill & Peterson's LLY Position: Q3 2026 in Review
Richards, Merrill & Peterson increased its Eli Lilly (LLY) stake by 8.6% in Q3 2026, buying an estimated $117K and bringing the position to 1,255 shares worth $1.45M. The position accounts for 0.44% of the portfolio, ranked #57.
Richards, Merrill & Peterson first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Richards, Merrill & Peterson held 1,255 shares of Eli Lilly worth $1.45M as of Q3 2026.
- Richards, Merrill & Peterson bought 99 Eli Lilly shares in Q3 2026, an estimated $117K.
- Eli Lilly made up 0.44% of Richards, Merrill & Peterson's portfolio in Q3 2026, its #57 holding.
- Richards, Merrill & Peterson first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Richards, Merrill & Peterson's 13F filing for Q3 2026, filed 19 Oct 2026.